SCHEMBL12442000

SCHEMBL12442000

CCN1C(=O)/C(=C\c2ccc(C)cc2)O/C1=N/C1CCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.38
MEN1 O00255 8/20 0.38
KDM4E B2RXH2 8/20 0.38
NPSR1 Q6W5P4 3/20 0.38
KLK7 P49862 2/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 6/20 0.36
ALDH1A1 P00352 6/20 0.36
HPGD P15428 3/20 0.36
CYP1A2 P05177 2/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
NFKB1 P19838 1/20 0.36
CYP2C19 P33261 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
MAPT P10636 7/20 0.36
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13964810 1.00 KMT2A (0.38) KMT2AMEN1KDM4ENPSR1KLK7
SCHEMBL1104387 0.94 KMT2A (0.35) KMT2AMEN1KDM4ENPSR1KLK7
SCHEMBL12442004 0.94 KMT2A (0.35) KMT2AMEN1KDM4ENPSR1KLK7
SCHEMBL13360052 0.90 PIM1 (0.34) KMT2AMEN1KDM4ELMNASMN1; SMN2
SCHEMBL12462884 0.88 KMT2A (0.37) KMT2AMEN1KDM4ELMNASMN1; SMN2
SCHEMBL1104318 0.88 KMT2A (0.37) KMT2AMEN1KDM4ELMNASMN1; SMN2
SCHEMBL12442002 0.88 SMN1; SMN2 (0.42) KMT2ALMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL13964815 0.88 SMN1; SMN2 (0.42) KMT2ALMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL12441961 0.87 CYBB (0.44) KMT2AMEN1KDM4ENPSR1LMNA
SCHEMBL1104341 0.87 CYBB (0.44) KMT2AMEN1KDM4ENPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9032876-B2 Lithographic printing plate precursor, lithographic printing plate platemaking method, and polymerizable monomer FUJIFILM CORPORATION (JP) 2015-05-19 US disclosed
US-20110174179-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR, LITHOGRAPHIC PRINTING PLATE PLATEMAKING METHOD, AND POLYMERIZABLE MONOMER FUJIFILM CORPORATION (JP) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110174179-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR, LITHOGRAPHIC PRINTING PLATE PLATEMAKING METHOD, AND POLYMERIZABLE MONOMER SORT1, ELOVL6, SCD5 KMT2A 4156/4885MEN1 3045/4885KDM4E 2945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.